In a feedback loop regulation, mutant IDH1 reduces HIF-1α-dependent TNC expression and decreases the aggressiveness of the gliomas [101] through changes in the endothelial cells and the microglia [102] and by promoting the acquisition of a mesenchymal stem-like phenotype by tumor cells [103]. The gene discussed is IDH1; the disease is central nervous system cancer.